FDA — authorised 14 September 2017
- Marketing authorisation holder: BAYER HEALTHCARE PHARMS
- Status: approved
🇺🇸 Aliqopa in United States
FDA authorised Aliqopa on 14 September 2017
Marketing authorisation
Aliqopa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Aliqopa approved in United States?
Yes. FDA authorised it on 14 September 2017.
Who is the marketing authorisation holder for Aliqopa in United States?
BAYER HEALTHCARE PHARMS holds the US marketing authorisation.